The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation

被引:19
作者
Taegtmeyer, Anne B. [1 ,2 ]
Rogers, Paula [2 ]
Breen, Jane B. [2 ]
Barton, Paul J. [1 ]
Banner, Nicholas R. [2 ]
Yacoub, Magdi H. [1 ]
机构
[1] Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England
[2] Harefield Hosp, Transplant Unit, Harefield UB9 6JH, Middx, England
关键词
D O I
10.1016/j.healun.2008.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia is associated with a poor prognosis in heart failure. Recent studies have also suggested that anemia may be a predictor of survival after heart transplantation. Methods: We investigated whether anemia before or after orthotopic cardiac transplantation affected post-transplant survival and analyzed data from a historical cohort of 267 consecutive adult patients who underwent transplantation between 1994 and 1999. Hemoglobin levels immediately before and at 6 weeks after orthotopic cardiac transplantation were recorded. Anemia was defined as a hemoglobin level less than 12 g/dl. The outcome was all-cause mortality. Survival analysis was performed using the Kaplan-Meier method and Cox proportional hazards models. Results: Pre-transplant anemia was present in 26% (n= 70). One-year survival was 70% in subjects who were anemic before transplantation compared with 81% in those who were not (p = 0.03). Multivariate analysis showed a 1-year mortality hazard ratio for pre-transplant anemic subjects of 1.77 (95% confidence interval, 1.03 3.0, p = 0.038). Anemia was more prevalent after transplantation (78%). There was no difference in 1-year survival between post-transplant anemic and non-anemic subjects. Conclusion: Anemia before, but not after transplantation, is a common independent predictor of 1-year survival in cardiac transplant patients.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 24 条
[1]   Anemia and its relationship to clinical outcome in heart failure [J].
Anand, I ;
McMurray, JJV ;
Whitmore, J ;
Warren, M ;
Pham, A ;
McCamish, MA ;
Burton, PBJ .
CIRCULATION, 2004, 110 (02) :149-154
[2]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[3]   Factors affecting survival after heart transplantation: Comparison of pre- and post-1999 listing protocols [J].
Bove, AA ;
Kashem, A ;
Cross, RC ;
Wald, J ;
Furukawa, S ;
Berman, GO ;
McClurken, JB ;
Eisen, HJ .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (01) :42-47
[4]   Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival [J].
Campise, M ;
Mikhail, A ;
Quaschning, T ;
Snyder, J ;
Collins, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 :8-12
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure [J].
Ezekowitz, JA ;
McAlister, FA ;
Armstrong, PW .
CIRCULATION, 2003, 107 (02) :223-225
[7]   Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure [J].
Felker, GM ;
Gattis, WA ;
Leimberger, JD ;
Adams, KF ;
Cuffe, MS ;
Gheorghiade, M ;
O'Connor, CM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :625-628
[8]   Anemia as a risk factor and therapeutic target in heart failure [J].
Felker, GM ;
Adams, KF ;
Gattis, WA ;
O'Connor, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (05) :959-966
[9]  
Freudenberger Ronald S, 2003, Curr Opin Crit Care, V9, P356, DOI 10.1097/00075198-200310000-00004
[10]  
FROST AE, 1993, TRANSPLANTATION, V56, P1008